It is of some interest that the association with NAFLD severity was stronger for FGF19 than for FGF21 both in terms of NASH and fibrosis, even if FGF19 and FGF21 were expectedly strictly associated (data not shown). The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatohepatitis.